113,10 <%= Resources.Global.txtDown %>
Opdateret 19-07-2019
Ændring % -0,35% Fald i aktiekurs
Ændring -0,40 Fald i aktiekurs
Volume 119.284
Høj 115,60
Lav 112,60
Åben 114,00
ISIN FR0010259150
Seneste luk 113,50
# af aktier 83,81M
Markedsværdi 9.478,76M EUR
I dag

Market closed
Ipsen
Markedet er lukket, åbner klokken 09:00
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  113,10 1,3% Stigning i aktiekurs -3,3% Fald i aktiekurs -3,8% Fald i aktiekurs -6,2% Fald i aktiekurs -21,0% Fald i aktiekurs
Powered by TradingView

Firmaprofil

Ipsen SA is a specialty and generic drug manufacturing company. The company's main therapeutic areas include oncology, endocrinology, neurosciences, and primary care. Ipsen maintains two segments: specialty care and primary care. The company derives most of its sales from the specialty care segment, with a vast majority of sales being generated in Western European countries. Ipsen's research and development strategy focuses on peptides and toxins. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
20. juli 2019 21:56:30
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190703.1 - EUROWEB3 - 2019-07-20 21:56:30 - 2019-07-20 21:56:30 - 1 - Website: OKAY